NAPA Reauthorization Act
Bill: S.4203 | Sponsor: Sen. Collins, Susan M. (R-ME)
Policy area: Health

Summary:
NAPA Reauthorization Act
This bill extends through 2035 and makes other changes to the National Alzheimer's Project. This project supports coordination of federal planning, programs, and other efforts to address Alzheimer's disease and related dementias.
In particular, the bill incorporates a focus on promoting healthy aging and reducing risk factors associated with cognitive decline.
The bill also expands the membership of the Advisory Council on Alzheimer's Research, Care, and Services to include (1) a researcher with experience recruiting and retaining diverse clinical trial participants, (2) an individual diagnosed with Alzheimer's disease, and (3) representatives from additional federal agencies (e.g., the Department of Justice and the Office of Management and Budget).

To extend the National Alzheimer's Project.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``NAPA Reauthorization Act''.

SEC. 2. EXTENSION OF PROJECT.

    Section 2 of the National Alzheimer's Project Act (42 U.S.C. 11225) 
is amended--
            (1) in subsection (c)--
                    (A) in paragraph (2), by striking ``and 
                coordination of'' and inserting ``on, and coordination 
                of,'';
                    (B) in paragraph (4)--
                            (i) by redesignating subparagraphs (A) and 
                        (B) as subparagraphs (B) and (C), respectively; 
                        and
                            (ii) by inserting before subparagraph (B), 
                        as so redesignated, the following:
                    ``(A) promotion of healthy aging and reduction of 
                risk factors for Alzheimer's disease;'';
                    (C) in paragraph (5), by striking ``; and'' and 
                inserting a semicolon;
                    (D) by redesignating paragraph (6) as paragraph 
                (7); and
                    (E) by inserting after paragraph (5) the following:
            ``(6) provide information on, and promote the adoption of, 
        healthy behaviors that may reduce the risk of cognitive decline 
        and promote and protect cognitive health; and'';
            (2) in subsection (d)(2)--
                    (A) by inserting ``, across public and private 
                sectors,'' after ``Nation's progress''; and
                    (B) by inserting ``, including consideration of 
                public-private collaborations, as appropriate'' before 
                the period;
            (3) in subsection (e)--
                    (A) in paragraph (2)--
                            (i) in subparagraph (A), by adding at the 
                        end the following:
                            ``(xi) A designee of the Department of 
                        Justice.
                            ``(xii) A designee of the Federal Emergency 
                        Management Agency.
                            ``(xiii) A designee of the Social Security 
                        Administration.
                            ``(xiv) A designee of the Office of 
                        Management and Budget.''; and
                            (ii) in subparagraph (B)--
                                    (I) in clause (v)--
                                            (aa) by striking ``2 
                                        researchers'' and inserting ``3 
                                        researchers''; and
                                            (bb) by striking ``; and'' 
                                        and inserting ``, including at 
                                        least one researcher with 
                                        demonstrated experience in 
                                        recruitment and retention of 
                                        diverse cohorts of trial 
                                        participants;'';
                                    (II) in clause (vi), by striking 
                                the period and inserting ``; and''; and
                                    (III) by adding at the end the 
                                following:
                            ``(vii) an individual with a diagnosis of 
                        Alzheimer's disease.'';
                    (B) in paragraph (5)--
                            (i) in subparagraph (A)--
                                    (I) by striking ``an initial 
                                evaluation'' and inserting ``annual 
                                evaluations''; and
                                    (II) by striking ``research, 
                                clinical'' and inserting ``research, 
                                risk reduction, public health, 
                                clinical'';
                            (ii) in subparagraph (B), by striking 
                        ``initial'';
                            (iii) in subparagraph (C)--
                                    (I) in the matter preceding clause 
                                (i), by striking ``initial''; and
                                    (II) in clause (ii), by inserting 
                                ``and reduce disparities'' before the 
                                semicolon; and
                            (iv) in subparagraph (D), by striking 
                        ``annually thereafter, an evaluation'' and 
                        inserting ``annual evaluations''; and
                    (C) in paragraph (6), by striking ``2025'' and 
                inserting ``2035'';
            (4) in subsection (g)(3)(A)(ii), by inserting ``and reduce 
        disparities'' before the semicolon; and
            (5) in subsection (h), by striking ``2025'' and inserting 
        ``2035''.
                                 <all>